Australia’s melanoma fight just got a game-changing boost: Professor Georgina Long, Australia’s top scientist and 2024 Australian of the Year, is leading a global trial for a revolutionary personalized mRNA therapy. For high-risk melanoma patients after surgery, this custom-made treatment—paired with immunotherapy—has shown stunning early results, slashing cancer recurrence far more effectively than immunotherapy alone. Scientists design each dose to target a patient’s unique tumor mutations, turning the immune system into a precision weapon against cancer. With melanoma rates soaring in Australia, this breakthrough could save thousands. While safety looks solid and longer-term survival data is still being tracked, regulatory approval could take up to two years before it reaches patients. This isn’t just science—it’s hope made tangible.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
